BGI Group has won the latest round in its battle with Illumina over DNA sequencing patents.
And it won big.
Partner David Bilsker led a trial team to a $333 million verdict for infringement of two patents owned by BGI Group, while also invalidating two patents asserted by competitor Illumina.
May 09, 2022 at 01:29 PM
3 minute read
The original version of this story was published on Delaware Business Court Insider
BGI Group has won the latest round in its battle with Illumina over DNA sequencing patents.
And it won big.
Presented by BigVoodoo
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS